The U.S. Department of Health has announced that it favors reclassifying marijuana, but traders would do well not to be sucked in by the recent surge in cannabis names.
TLRY bought eight beer brands from Anheuser-Busch InBev, boosting its 'meme' stock potential.
The quarter wasn't great, but the guidance was promising.
Though it is tempting, there are a host of reasons why I'm not bottom fishing.
With likely passage of new legislation, the pot industry might have a remedy for the nausea it gave investors.
The focus is on positioning for the election and CPI Thursday.
It's a dicey play as the price action isn't defined as yet and the ETF still could break lower.
TLRY is probably not that close to sustained profitability, but it has built the balance sheet to tough out these hard times.
Let's review the charts and indicators of MSOS.
There was some interesting action under the surface in the market Thursday .
The shares are sinking despite an EPS and revenue beat.
There are much broader implications beyond my unprofitable venture into cannabis stocks.
These names provide exposure to the cannabis industry, but also pay hefty dividends to shareholders.
It would be foolish to ignore the Fed chairman, who could sneeze and turn everyone bearish.
Meanwhile, the market indexes remain on cruise control as traders await Jerome Powell's utterances at Jackson Hole.
It seems to me that federal legislation is inevitable.
The ETF is showing signs of perking up and the micro-cap is a maker of electric outboard motors.
The risk/reward profiles of AGFY and MAP are enticing.
Tech stocks didn't disappear after the dot-com bubble; the cream of the crop came back healthier than ever. And so will the best-run cannabis stocks.
Shares of the cannabis company have provided a rude awakening for buy-and-hold investors.
The same can be said of cannabis stocks as fresh talk of federal legislation to legalize marijuana likely is just that… talk.
I have my eye on relative strength in groups that have lagged for a very long time.
Many stocks are very oversold, and sentiment is about as bad as it gets.
Here we'll hash out the differences among cannabis players and see high how Roundhill Investment's The Cannabis ETF can go.
Pressure on fertilizer supplies due to sanctions against Russia because of the war in Ukraine makes the potash producer a star performer in a down market.
Tilray is okay in my book for speculation.
There should be some better trading action and setups as things pull back.
It isn't brave to trade without a game plan; it's foolhardy and can result in big losses.
Small-caps and growth names are relatively weak.
Let's check out the 21-day exponential moving averages of SPY and QQQ for clues and also look at three stocks for trading ideas.